High-fat foods take a long time to digest due to the structure of triglycerides, or the main form of fat in foods
Research applications In-vitro modeling of synergistic GHRH/GHRP receptor cross-talk Pre-clinical study of pulsatile GH-secretagogue dynamics Comparative receptor-pathway research (cAMP vs calcium convergence) Reference standard for analytical characterization of blended preparations Key facts Combines a GHRH-receptor analog with a selective GHS-R1a agonist Nominal 5mg + 5mg per-component loading per vial Components act through mechanistically independent, convergent pathways Supplied as a co-lyophilized research powder for in-vitro use Product specifications Class: GHRH analog + GHRP/ghrelin-receptor agonist research blend Also known as: Mod-GRF + Ipamorelin blend Form: Lyophilized powder vial Purity: 99% (HPLC verified) Testing: Independent third-party HPLC + mass spectrometry Documentation: Certificate of analysis per batch Storage: Store lyophilized at -20C
Why KLOW draws research interest These are the directions researchers and the peptide community most often explore KLOW for so you know youre in the right place
Your GP can provide an accurate assessment of your current health status, discuss evidence-based treatment options that are currently available and licensed in the UK, and help you understand whether you might be eligible for clinical trial participation
doi: 10.1056/NEJMoa1600869 [DOI] [PMC free article] [PubMed] [Google Scholar] 14.Wiggins T, Antonowicz SS, Markar SR
Contact Dermatitis, 34: 414-418
